Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Gupta

Showing results (311-320 of 314) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 314 results.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Nature Medicine|June 15, 2023
Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinomaAssaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Radiology|April 22, 2020
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused PanelAntonio C Westphalen, Charles E McCulloch, Jordan M Anaokar, et al.
Pageof 32

Showing results (311-320 of 314) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 314 results.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Nature Medicine|June 15, 2023
Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinomaAssaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Radiology|April 22, 2020
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused PanelAntonio C Westphalen, Charles E McCulloch, Jordan M Anaokar, et al.
Pageof 32